United Therapeutics (UTHR) Misses Q3 EPS by 14c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $538.30 +0.32%
EPS Growth %: +12.6%
Financial Fact:
Income from continuing operations before income taxes: 239.1M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +12.6%
Financial Fact:
Income from continuing operations before income taxes: 239.1M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $6.39, $0.14 worse than the analyst estimate of $6.53. Revenue for the quarter came in at $748.9 million versus the consensus estimate of $722.95 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Japan's Katayama, Us Treasury's Bessent Hold Online Talks, Source Says - Reuters
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
